» Authors » Luis Forga

Luis Forga

Explore the profile of Luis Forga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 400
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamayo I, Librero-Lopez J, Galbete A, Cambra K, Enguita-German M, Forga L, et al.
BMJ Open . 2023 Jan; 13(1):e066052. PMID: 36669840
Purpose: The CArdiovascular Risk in patients with DIAbetes in Navarra (CARDIANA cohort) cohort was established to assess the effects of sociodemographic and clinical variables on the risk of cardiovascular events...
2.
Forga L, Lopez-Andres N, Tamayo I, Fernandez-Celis A, Garcia-Mouriz M, Goni M
Endocrinol Diabetes Nutr (Engl Ed) . 2022 Jun; 69(5):322-330. PMID: 35697466
Aim: To determine the association and the prognostic value of soluble ST2 (sST2) levels in the development of diabetic retinopathy (DR), diabetic macular oedema (DMO) or diabetic nephropathy (DN), in...
3.
Guillen-Aguinaga S, Brugos-Larumbe A, Guillen-Aguinaga L, Ortuno F, Guillen-Grima F, Forga L, et al.
J Cardiovasc Dev Dis . 2022 Jan; 9(1). PMID: 35050235
(1) Background: Patients with schizophrenia have higher mortality, with cardiovascular diseases being the first cause of mortality. This study aims to estimate the excess risk of hospital admission for cardiovascular...
4.
Guillen-Aguinaga S, Forga L, Brugos-Larumbe A, Guillen-Grima F, Guillen-Aguinaga L, Aguinaga-Ontoso I
J Clin Med . 2021 Dec; 10(24). PMID: 34945149
Type 2 diabetes (T2D) is associated with increased cardiovascular morbidity, mortality, and hospital admissions. This study aimed to analyze how the differences in delivered care (variability of glycosylated hemoglobin (HbA1c)...
5.
Forga L, Lopez-Andres N, Tamayo I, Fernandez-Celis A, Garcia-Mouriz M, Goni M
Endocrinol Diabetes Nutr (Engl Ed) . 2021 Jul; PMID: 34274305
Aim: To determine the association and the prognostic value of soluble ST2 (sST2) levels in the development of diabetic retinopathy (DR), diabetic macular oedema (DMO) or diabetic nephropathy (DN), in...
6.
Galbete A, Cambra K, Forga L, Baquedano F, Aizpuru F, Lecea O, et al.
J Diabetes Complications . 2019 Nov; 33(12):107445. PMID: 31668588
Aims: The main objective was to assess, using real-practice primary care records, the degree of control of cardiovascular risk factor targets. Records were stratified by the presence of previous history...
7.
Basterra-Gortari F, Ruiz-Canela M, Martinez-Gonzalez M, Babio N, Sorli J, Fito M, et al.
Diabetes Care . 2019 Jun; 42(8):1390-1397. PMID: 31182491
Objective: To examine the effects of two Mediterranean eating plans (Med-EatPlans) versus a low-fat eating plan on the need for glucose-lowering medications. Research Design And Methods: From the Prevención con...
8.
Garcia-Arellano A, Martinez-Gonzalez M, Ramallal R, Salas-Salvado J, Hebert J, Corella D, et al.
Clin Nutr . 2019 Jan; 38(3):1221-1231. PMID: 30651193
Background: Inflammation is known to be related to the leading causes of death including cardiovascular disease, several types of cancer, obesity, type 2 diabetes, depression-suicide and other chronic diseases. In...
9.
Forga L, Chueca M, Tamayo I, Oyarzabal M, Toni M, Goni M
Pediatr Diabetes . 2018 Aug; 19(8):1416-1421. PMID: 30146715
Objective: To trace the evolution of type 1 diabetes (T1D) in Navarre in children under 15, between 1977 and 2016, and their characteristics at onset regarding age and sex. Subjects...
10.
Ibanez B, Galbete A, Goni M, Forga L, Arnedo L, Aizpuru F, et al.
BMC Public Health . 2018 Mar; 18(1):408. PMID: 29587788
Background: The aim of this study was to determine if the achievement of control targets in patients with type 2 diabetes was associated with personal socioeconomic factors and if these...